Alexander Hillisch
Overview
Explore the profile of Alexander Hillisch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
841
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mittal A, Martin M, Levin E, Adams C, Yang M, Provins L, et al.
Nat Struct Mol Biol
. 2025 Mar;
PMID: 40050463
No abstract available.
2.
Li F, Ackloo S, Arrowsmith C, Ban F, Barden C, Beck H, et al.
J Chem Inf Model
. 2024 Nov;
64(22):8521-8536.
PMID: 39499532
The CACHE challenges are a series of prospective benchmarking exercises to evaluate progress in the field of computational hit-finding. Here we report the results of the inaugural CACHE challenge in...
3.
Mittal A, Martin M, Levin E, Adams C, Yang M, Provins L, et al.
Nat Struct Mol Biol
. 2024 Jun;
31(12):1964-1974.
PMID: 38898101
Epilepsy is a common neurological disorder characterized by abnormal activity of neuronal networks, leading to seizures. The racetam class of anti-seizure medications bind specifically to a membrane protein found in...
4.
Chen B, Liu C, Cong W, Gao F, Zou Y, Su L, et al.
Chem Sci
. 2023 Oct;
14(41):11499-11506.
PMID: 37886087
Stapled peptides are regarded as the promising next-generation therapeutics because of their improved secondary structure, membrane permeability and metabolic stability as compared with the prototype linear peptides. Usually, stapled peptides...
5.
Roehrig S, Ackerstaff J, Jimenez Nunez E, Teller H, Ellerbrock P, Meier K, et al.
J Med Chem
. 2023 Sep;
66(17):12203-12224.
PMID: 37669040
Activated coagulation factor XI (FXIa) is a highly attractive antithrombotic target as it contributes to the development and progression of thrombosis but is thought to play only a minor role...
6.
Ackloo S, Antolin A, Bartolome J, Beck H, Bullock A, Betz U, et al.
RSC Med Chem
. 2023 Jun;
14(6):1002-1011.
PMID: 37360399
Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging 'open' principles to develop a pharmacological tool for every human protein. These tools are...
7.
Ackloo S, Al-Awar R, Amaro R, Arrowsmith C, Azevedo H, Batey R, et al.
Nat Rev Chem
. 2022 Jul;
6(4):287-295.
PMID: 35783295
One aspirational goal of computational chemistry is to predict potent and drug-like binders for any protein, such that only those that bind are synthesized. In this Roadmap, we describe the...
8.
Muller S, Ackloo S, Al Chawaf A, Al-Lazikani B, Antolin A, Baell J, et al.
RSC Med Chem
. 2022 Feb;
13(1):13-21.
PMID: 35211674
Twenty years after the publication of the first draft of the human genome, our knowledge of the human proteome is still fragmented. The challenge of translating the wealth of new...
9.
Goller A, Kuhnke L, Ter Laak A, Meier K, Hillisch A
Methods Mol Biol
. 2021 Nov;
2390:61-101.
PMID: 34731464
The well-known concept of quantitative structure-activity relationships (QSAR) has been gaining significant interest in the recent years. Data, descriptors, and algorithms are the main pillars to build useful models that...
10.
Hillisch A, Gericke K, Allerheiligen S, Roehrig S, Schaefer M, Tersteegen A, et al.
J Med Chem
. 2020 Oct;
63(21):12574-12594.
PMID: 33108181
Despite extensive research on small molecule thrombin inhibitors for oral application in the past decades, only a single double prodrug with very modest oral bioavailability has reached human therapy as...